首页> 美国卫生研究院文献>Cell Communication and Signaling : CCS >Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels AKT and ERK1/2 signaling
【2h】

Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels AKT and ERK1/2 signaling

机译:美金刚增强阿糖胞苷诱导的急性白血病细胞死亡与抑制Kv1.3钾通道AKT和ERK1 / 2信号有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTreatment of acute leukemia is challenging and long-lasting remissions are difficult to induce. Innovative therapy approaches aim to complement standard chemotherapy to improve drug efficacy and decrease toxicity. Promising new therapeutic targets in cancer therapy include voltage-gated Kv1.3 potassium channels, but their role in acute leukemia is unclear. We reported that Kv1.3 channels of lymphocytes are blocked by memantine, which is known as an antagonist of neuronal N-methyl-D-aspartate type glutamate receptors and clinically applied in therapy of advanced Alzheimer disease. Here we evaluated whether pharmacological targeting of Kv1.3 channels by memantine promotes cell death of acute leukemia cells induced by chemotherapeutic cytarabine.
机译:背景急性白血病的治疗具有挑战性,难以诱导长期缓解。创新的治疗方法旨在补充标准化疗以提高药物疗效并降低毒性。癌症治疗中有希望的新治疗靶点包括电压门控的Kv1.3钾通道,但尚不清楚它们在急性白血病中的作用。我们报道了淋巴细胞的Kv1.3通道被美金刚阻断,美金刚被称为神经元N-甲基-D-天冬氨酸型谷氨酸受体的拮抗剂,并在临床上用于晚期阿尔茨海默氏病的治疗。在这里,我们评估了美金刚对Kv1.3通道的药理作用是否促进了化疗阿糖胞苷诱导的急性白血病细胞的细胞死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号